News
SBIR contract solicitation for NIH and CDC just announced
Just released — The annual announcement of Small Business Innovation Research (SBIR) contract topics for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) was released on August 2, 2024, PHS-2025-1.
While the lion’s share of the over $1.3 billion annual budget for SBIR programs at NIH and CDC are provided through the grant mechanism, once a year there is a call for SBIR proposals supported through the contract mechanism. The list of Institutes and Centers participating in the solicitations varies year to year as do the topics of interest. This year, topics range from “Leveraging Multimodal and Generative Artificial Intelligence to Advance the Application of Social Robotics in Caregiving” (National Institute on Aging) to “Rapid Diagnostic Assays for Self-Monitoring of Acute or Rebound HIV-1 Infection” (National Institute of Allergy and Infectious Diseases) to “Data Science Solutions to Characterize Polysubstance Use Behavior from Online Sources” (National Center for Injury Prevention and Control). Six NIH Institutes and 3 CDC Centers are participating in the contract offering this year.
See the full list of eligible topics, expected number of awards for each topic, application requirements, and expected award dates at:
https://sam.gov/opp/b6c0bad2a0924520a704bb1bca846615/view
Life Science Associates can work with you to develop your non-dilutive funding strategy and help prepare compelling and highly competitive SBIR/STTR grant and contract applications. Read more about our team and contact us for a free initial consultation to see if we are a good fit for your needs.
Applications are due October 18, 2024, 5 PM, EDT.
Welcome
Welcome to Life Science Associates!
I am thrilled to introduce you to Life Science Associates (LSA), a new venture born from my deep passion for science, medicine, and business. I am looking forward to working with the many talented professionals in the LSA community who share my passion and commitment to support the growth of emerging life science companies and entrepreneurs.
I want to express my sincere gratitude to everyone who has supported me along the way—colleagues, friends, family, and mentors. Your encouragement has been instrumental in bringing the vision of Life Science Associates to life. A hearty “thank you” to all of you!
What We’re All About
Small businesses are vital to the U.S. economy. They drive job creation, innovation, and the development of new products and services. In fact, small businesses make up 44% of U.S. economic activity. But we also know that many early-stage companies face significant hurdles, and many don’t make it past their initial stages. The challenges are often predictable, but they can be overcome with the right support.
That’s where Life Science Associates comes in. Our goal is to support early-stage life science companies from their launch and throughout their early years. We’re here to help with funding strategies, streamlining and strengthening operations, and providing valuable insights from our collective experience in science, medicine, business, and investment. We believe that our combined expertise can make a real difference in helping you succeed in bringing new therapeutics, diagnostics, devices, and practices to the market and widespread use.
Stay in Touch
We will share regular updates on our progress and on important issues facing emerging life science companies. If you’re part of a new life science venture and interested in working with us, we would love to hear from you!
Thank you for being a part of this exciting journey.
Best regards,
Sharon H Hrynkow PhD
Founder & President, Life Science Associates LLC